Catalyst Wire Dossier Catalyst Wire Dossier

AD5-based oral norovirus vaccine

Adenovirus type 5 vector-based oral norovirus vaccine · Vaxart
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AD5-based oral norovirus vaccine, covering 2024-05-22 to 2024-05-22. Get the full timeline:

Most recent: Clinical Trial Update: Immunogenicity & Safety Study of Adenovirus Type 5 (AD5) Based Oral Norovirus Vaccines [Phase 1, Phase 2]

See pricing